Yuting Ji

Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

The miR-148/152 Family Suppresses Apoptosis and Necroptosis for Cancer Evasion Through Direct RIPK1 Repression.

The miR-148/152 Family Suppresses Apoptosis and Necroptosis for Cancer Evasion Through Direct RIPK1 Repression.

Journal: Cell biology international

Published: September 23, 2025

DNMT1 blocks SOX21-repressed CKS2 transcription to promote gastric cancer progression.

DNMT1 blocks SOX21-repressed CKS2 transcription to promote gastric cancer progression.

Journal: BMC cancer

Published: April 21, 2025

Discovery of Zharp1-163 as a dual inhibitor of ferroptosis and necroptosis for the treatment of inflammatory disorders and kidney injury.

Discovery of Zharp1-163 as a dual inhibitor of ferroptosis and necroptosis for the treatment of inflammatory disorders and kidney injury.

Journal: Cell death discovery

Published: March 31, 2025

Clinical efficacy of Endostar continuous infusion combined with concurrent chemoradiotherapy in the treatment of oesophageal squamous cell carcinoma.

Clinical efficacy of Endostar continuous infusion combined with concurrent chemoradiotherapy in the treatment of oesophageal squamous cell carcinoma.

Journal: Frontiers in medicine

Published: July 11, 2024

A novel RIPK1 inhibitor reduces GVHD in mice via a nonimmunosuppressive mechanism that restores intestinal homeostasis.

A novel RIPK1 inhibitor reduces GVHD in mice via a nonimmunosuppressive mechanism that restores intestinal homeostasis.

Journal: Blood

Published: June 09, 2022

A molecularly imprinted biosensor based on water-compatible and electroactive polymeric nanoparticles for lysozyme detection.

A molecularly imprinted biosensor based on water-compatible and electroactive polymeric nanoparticles for lysozyme detection.

Journal: Talanta

Published: August 27, 2021

Discovery of a Potent RIPK3 Inhibitor for the Amelioration of Necroptosis-Associated Inflammatory Injury.

Discovery of a Potent RIPK3 Inhibitor for the Amelioration of Necroptosis-Associated Inflammatory Injury.

Journal: Frontiers in cell and developmental biology

Published: September 14, 2020

Doxorubicin sensitizes cancer cells to Smac mimetic via synergistic activation of the CYLD/RIPK1/FADD/caspase-8-dependent apoptosis.

Doxorubicin sensitizes cancer cells to Smac mimetic via synergistic activation of the CYLD/RIPK1/FADD/caspase-8-dependent apoptosis.

Journal: Apoptosis : an international journal on programmed cell death

Published: May 18, 2020

Showing 1-8 of 8

Last Updated: 09/26/2026